NCT03382769 is a NA clinical trial of Cochlear implantation in Hearing Loss, Sensorineural, sponsored by Cochlear.

Who is sponsoring NCT03382769?

NCT03382769 is sponsored by Cochlear.

What drugs are being tested in NCT03382769?

Interventions in NCT03382769: Cochlear implantation.

What condition does NCT03382769 study?

NCT03382769 studies Hearing Loss, Sensorineural, Hearing Loss, Bilateral.

Is NCT03382769 still recruiting?

NCT03382769 is currently terminated. Last updated 22 December 2022.

Are results published for NCT03382769?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-12-22 · How we verify

NCT03382769

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hearing Loss in Older Adults Study

Terminated NA Results posted Last updated 22 December 2022

What this trial tests

NA trial testing Cochlear implantation in Hearing Loss, Sensorineural in 1 participant. Terminated before completion.

Timeline

27 March 2019

Primary endpoint
4 January 2020

4 January 2020

Quick facts

Lead sponsor	Cochlear
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	1
Start date	27 March 2019
Primary completion	4 January 2020
Estimated completion	4 January 2020
Sites	8 locations across United States

Drugs / interventions tested

Cochlear implantation

Conditions studied

Hearing Loss, Sensorineural — all drugs for Hearing Loss, Sensorineural →
Hearing Loss, Bilateral — all drugs for Hearing Loss, Bilateral →

Sponsor

Cochlear — full company profile →

Who can join

Adults 65 to 85, any sex, with Hearing Loss, Sensorineural or Hearing Loss, Bilateral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, 1:1 randomized controlled trial of immediate versus delayed cochlear implantation (CI) on hearing handicap, communicative function, loneliness, mental wellbeing, and cognitive functioning. Participants are randomized 1:1 to an immediate cochlear implant intervention group versus a hearing aid control intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cochlear implantation

Trials testing the same drug.

NCT05079867 — Cochlear Trauma, Functional and Structural Preservation in Cochlear Implant Surgery · unknown
NCT05052944 — Single-sided Deafness and Cochlear Implantation · completed
NCT04610112 — Safety and Performance of HiRes Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss · completed
NCT04934605 — Genotype-phenotype Correlation of SLC26A4 in CI Patients With EVA · unknown

Other recruiting trials for Hearing Loss, Sensorineural

Currently open trials in the same condition.

NCT06499805 — Barriers and Facilitators to OTC Hearing Aids Success · NA · recruiting
NCT06560918 — Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids · NA · recruiting
NCT06882889 — Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL · NA · recruiting
NCT06664697 — Post-Market Clinical Investigation of the IotaSOFT Insertion System · recruiting
NCT06268340 — Hearing and Structure Preservation Via ECochG · NA · recruiting

Other Cochlear trials

Trials by the same sponsor.

NCT07077070 — Investigating Electrical Categorical Loudness Scaling Using a Mobile Research App in Experienced Adult Cochlear Implant · NA · completed
NCT07156461 — Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients · NA · completed
NCT06338670 — Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users · NA · completed
NCT06298396 — Investigating Stimulation Parameter and Electrode Mode Changes on Speech Perception in Experienced Adult Cochlear Implan · NA · completed
NCT06100393 — New Algorithms to Signal Processing for Speech Enhancement in Adult Cochlear Implant Recipients. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03382769 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cochlear
Last refreshed: 22 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03382769.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing